Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Loukides (Athens, Greece). Non invasive biomarkers in the diagnostic and prognostic evaluation of Pulmonary Fibrosis. Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of diagnostic methods in pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 539s Year: 2006 Diagnostic and prognostic value of advanced imaging modalities in patients with suspected cardiac sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 Prognostic validation of cryobiopsy for the diagnosis of interstitial lung diseases Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound Year: 2019 Six-minute-walk test parameters in the prognostic evaluation of fibrotic lung diseases Source: International Congress 2014 – ILDs 4 Year: 2014 PP219 – Development and Validation of a Novel Prognostic Nomogram for COPD patients with Pulmonary Hypertension Source: ERS Lung Science Conference 2021 Year: 2021 Non-invasive diagnosis of lymphangioleiomyomatosis: new biomarkers Source: International Congress 2018 – Russian Speaking Programme 2018: Part II Year: 2018 Evaluating the utility of mesothelin in diagnosing mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Multidisciplinary approach in the diagnosis of Idiopathic Pulmonary Fibrosis: role of transbronchial lung cryobiopsy and surgical biopsy on a cohort of 153 patients. Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery Year: 2018 Invasive diagnostic procedures in nonhospital-acquired pneumonia: evaluation Source: Eur Respir J 2001; 18: Suppl. 33, 463s Year: 2001 Clinical pitfalls in diagnosing interstitial lung disease Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014 Invasive approaches in the diagnosis of ILDs Source: Virtual Congress 2020 – Interstitial lung diseases Year: 2020 Impact of diagnostic pitfalls on the management of pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 The CF-ABLE score: A 2-year evaluation of a 4-year prognostic tool Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Diagnostic impact of EUS(b)-FNA in diagnostics of sarcoidosis Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy Year: 2013 Serum ST2 in Idiopathic Pulmonary Fibrosis (IPF): a possible new biomarker of disease? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Predictive CT-parameters for detection with and diagnostic accuracy of EBUS-guided biopsy of suspected lung lesions Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016